Inflammation-related biomarkers, such as albumin and C-reactive protein (CRP), have been identified as prognostic indicators in RCC, with hypoalbuminemia and elevated CRP levels consistently associated with poor clinical outcomes [11–13]. The gene discussed is CRP; the disease is renal cell carcinoma.